Genomic Valley Biotech Limited (BOM:539206)

Genomic Valley Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	79	179	106	66	76	72
Market Cap Growth	-62.80%	68.80%	59.59%	-12.12%	4.87%	172.52%
Enterprise Value	79	175	106	66	76	87
Last Close Price	26.00	58.59	34.71	21.75	24.75	23.60
PE Ratio	-	50.26	698.35	10.25	-	-
PS Ratio	16.09	21.21	64.23	2.44	107.14	34.64
PB Ratio	2.02	4.59	2.99	1.88	2.63	1.61
P/TBV Ratio	2.02	4.59	2.99	1.88	2.63	1.61
P/FCF Ratio	-	1012.58	-	-	-	-
P/OCF Ratio	-	666.52	-	-	-	4.86
EV/Sales Ratio	16.08	20.71	63.98	2.44	107.03	41.60
EV/EBITDA Ratio	141.19	39.77	694.00	7.55	-	-
EV/EBIT Ratio	150.93	40.00	747.67	7.62	-	-
EV/FCF Ratio	-	988.92	-	-	-	-
Debt / Equity Ratio	-	-	-	-	-	0.35
Net Debt / Equity Ratio	0.00	-0.01	0.00	-0.01	0.00	0.34
Net Debt / EBITDA Ratio	-0.13	-0.10	-0.40	-0.05	0.01	-11.45
Net Debt / FCF Ratio	-	-2.56	0.30	0.05	0.00	-16.24
Asset Turnover	-	0.19	0.04	0.66	0.01	0.03
Quick Ratio	-	4.93	3.21	2.53	0.08	0.10
Current Ratio	-	5.73	3.68	2.89	5.31	0.19
Return on Equity (ROE)	-	9.57%	0.43%	20.24%	-0.25%	-11.73%
Return on Assets (ROA)	-	6.29%	0.20%	13.25%	-5.00%	-2.59%
Return on Invested Capital (ROIC)	-0.98%	9.54%	0.40%	27.35%	-10.26%	-5.17%
Return on Capital Employed (ROCE)	-	11.20%	0.40%	24.70%	-12.70%	-4.80%
Earnings Yield	-0.45%	1.99%	0.14%	9.76%	-0.12%	-7.75%
FCF Yield	-	0.10%	-0.19%	-11.72%	-28.17%	-1.31%
Buyback Yield / Dilution	3.56%	-0.24%	0.70%	1.79%	-1.91%	-0.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.